Skip to Content
Merck
  • Acute retinal necrosis associated with Epstein-Barr virus: immunohistopathologic confirmation.

Acute retinal necrosis associated with Epstein-Barr virus: immunohistopathologic confirmation.

JAMA ophthalmology (2014-04-20)
Shlomit Schaal, Aleksandr Kagan, Yujuan Wang, Chi-Chao Chan, Henry J Kaplan
ABSTRACT

Acute retinal necrosis (ARN) is an infectious retinitis primarily caused by the herpesviruses. Although the Epstein-Barr virus (EBV) has been implicated as a cause of ARN, to our knowledge, there has been no histopathologic documentation. We report the clinical history and histopathologic confirmation that EBV can cause ARN. Clinical course and histopathology of a patient diagnosed with ARN caused by infection with EBV confirmed by molecular pathology. Epstein-Barr virus is a recognized cause of intraocular inflammation and has been implicated as a possible cause of ARN. However, to our knowledge, tissue demonstration of EBV in a patient with ARN has not previously been reported. We identified the organism in the necrotic retina of a patient receiving immunosuppression because of idiopathic pulmonary fibrosis.

MATERIALS
Product Number
Brand
Product Description

Valine, European Pharmacopoeia (EP) Reference Standard
Supelco
Acyclovir, Pharmaceutical Secondary Standard; Certified Reference Material
Aciclovir, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Valacyclovir hydrochloride hydrate, ≥98% (HPLC), solid
Supelco
L-Valine, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
L-Valine, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Sigma-Aldrich
L-Valine, reagent grade, ≥98% (HPLC)
SAFC
L-Valine
Sigma-Aldrich
L-Valine, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, 98.5-101.0%
Valaciclovir hydrochloride (anhydrous), European Pharmacopoeia (EP) Reference Standard
USP
Acyclovir, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
L-Valine, BioUltra, ≥99.5% (NT)
USP
Valacyclovir hydrochloride, United States Pharmacopeia (USP) Reference Standard
Valaciclovir for system suitability, European Pharmacopoeia (EP) Reference Standard